Literature DB >> 8775225

Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.

K Tullus1, G W Noack, L G Burman, R Nilsson, B Wretlind, A Brauner.   

Abstract

UNLABELLED: Bronchopulmonary dysplasia (BPD) is a chronic lung disease often occurring in ventilator-treated very low birth weight infants. The aetiology of BPD is multifactorial and pulmonary immaturity, high oxygen concentrations, peak inspiratory pressure levels and large tidal volumes during prolonged mechanical ventilation are important factors. We measured in tracheobronchial aspirate fluid (TAF) the concentrations of the pro-inflammatory cytokines tumour necrosis factor alpha, interleukin-1 beta (IL-1 beta), IL-6, IL-8, and IL-1 receptor antagonist in infants requiring artificial ventilation for BPD (n = 17) or respiratory distress syndrome (RDS) (n = 15) or postoperatively after surgery (n = 15). The median levels of all studied cytokines in TAF were higher in infants with BPD without local or systemic corticosteroid treatment compared to the median TAF levels of BPD neonates treated with corticosteroids (P = 0.06-P < 0.01). The neonates with BPD not treated with corticosteroids also showed higher levels of the five studied cytokines in TAF compared to infants on short-time ventilator treatment (P < 0.01-P < 0.001) and compared to neonates with RDS (P = 0.07-P < 0.001). The corticosteroid treated neonates with BPD had TAF cytokine levels approaching those of the control neonates.
CONCLUSION: Tumour necrosis factors alpha, IL-1 beta, IL6, IL8 and IL1ra were markedly elevated in tracheobronchial aspirate fluids from neonates with bronchopulmonary dysplasia. Corticoid treatment seemed to reduce these levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8775225     DOI: 10.1007/bf02075762

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  36 in total

Review 1.  The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome.

Authors:  C A Dinarello
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

2.  Suppression of human alveolar macrophage-derived cytokines by amiloride.

Authors:  M W Rolfe; S L Kunkel; B Rowens; T J Standiford; E J Cragoe; R M Strieter
Journal:  Am J Respir Cell Mol Biol       Date:  1992-06       Impact factor: 6.914

3.  High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis.

Authors:  P M Suter; S Suter; E Girardin; P Roux-Lombard; G E Grau; J M Dayer
Journal:  Am Rev Respir Dis       Date:  1992-05

4.  Bronchopulmonary dysplasia: clinical presentation.

Authors:  E Bancalari; G E Abdenour; R Feller; J Gannon
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

5.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

Review 6.  The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.

Authors:  P C Ng
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

7.  Oxygen plus pressure plus time: the etiology of bronchopulmonary dysplasia.

Authors:  A G Philip
Journal:  Pediatrics       Date:  1975-01       Impact factor: 7.124

8.  Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups.

Authors:  S C Donnelly; R M Strieter; S L Kunkel; A Walz; C R Robertson; D C Carter; I S Grant; A J Pollok; C Haslett
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

9.  Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia.

Authors:  M C Mammel; T P Green; D E Johnson; T R Thompson
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

10.  Neonatal pulmonary cytology and bronchopulmonary dysplasia.

Authors:  G D'Ablang; B Bernard; I Zaharov; L Barton; B Kaplan; C P Schwinn
Journal:  Acta Cytol       Date:  1975 Jan-Feb       Impact factor: 2.319

View more
  24 in total

Review 1.  Pathogenesis and treatment of bronchopulmonary dysplasia.

Authors:  Jason Gien; John P Kinsella
Journal:  Curr Opin Pediatr       Date:  2011-06       Impact factor: 2.856

2.  Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants.

Authors:  B Jónsson; K Tullus; A Brauner; Y Lu; G Noack
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-11       Impact factor: 5.747

Review 3.  The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.

Authors:  Ronald I Clyman
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

4.  NF-kappaB in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome.

Authors:  A Bourbia; M A Cruz; H J Rozycki
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-07-27       Impact factor: 5.747

Review 5.  Physiology of transition from intrauterine to extrauterine life.

Authors:  Noah H Hillman; Suhas G Kallapur; Alan H Jobe
Journal:  Clin Perinatol       Date:  2012-12       Impact factor: 3.430

6.  IκB kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm.

Authors:  Ashley N Stouch; Rinat Zaynagetdinov; Whitney J Barham; Amanda M Stinnett; James C Slaughter; Fiona E Yull; Hal M Hoffman; Timothy S Blackwell; Lawrence S Prince
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

7.  Patent ductus arteriosus ligation alters pulmonary gene expression in preterm baboons.

Authors:  Nahid Waleh; Donald C McCurnin; Bradley A Yoder; Philip W Shaul; Ronald I Clyman
Journal:  Pediatr Res       Date:  2011-03       Impact factor: 3.756

8.  Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells.

Authors:  Bahman Saatian; Yutong Zhao; Donghong He; Steve N Georas; Tonya Watkins; Ernst Wm Spannhake; Viswanathan Natarajan
Journal:  Biochem J       Date:  2006-02-01       Impact factor: 3.857

Review 9.  Bronchopulmonary dysplasia: Pathogenesis and treatment.

Authors:  Asfia Banu Pasha; Xiao-Qing Chen; Guo-Ping Zhou
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

10.  beta6 Integrin subunit deficiency alleviates lung injury in a mouse model of bronchopulmonary dysplasia.

Authors:  Anna Hogmalm; Dean Sheppard; Urpo Lappalainen; Kristina Bry
Journal:  Am J Respir Cell Mol Biol       Date:  2009-08-28       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.